<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Functional neurological disorder following COVID-19</dc:title><dc:creator>Berlot,	Rok	(Avtor)
	</dc:creator><dc:creator>Asan,	Livia	(Avtor)
	</dc:creator><dc:creator>Nicholson,	Timothy R.	(Avtor)
	</dc:creator><dc:creator>Stanton,	Biba	(Avtor)
	</dc:creator><dc:creator>Pollak,	Thomas A.	(Avtor)
	</dc:creator><dc:creator>Edwards,	Mark J.	(Avtor)
	</dc:creator><dc:subject>COVID-19</dc:subject><dc:subject>conversion disorder</dc:subject><dc:subject>functional neurological disorder</dc:subject><dc:subject>neuropsychiatric manifestations</dc:subject><dc:subject>risk factors</dc:subject><dc:description>Background: Following COVID-19, an increased risk of neurological and psychiatric sequelae has been reported. Viral illnesses commonly trigger functional neurological disorder (FND). However, mechanisms beyond immediate biological effects may contribute to FND after COVID-19. While FND cases have been observed after COVID-19, the overall risk and contributing factors remain unclear. In this retrospective cohort study, we compared the rates of FND post-COVID-19 to other respiratory tract infections (RTIs), assessed the influence of disease severity, and the characteristics of newly diagnosed patients. Methods: We used TriNetX, a global electronic health record network. In total, 2,740,094 COVID-19 cases and 1846 post-COVID-19 FND cases were analysed. We compared FND incidence between 2 weeks and 6 months after COVID-19 to other RTIs and across cohorts of varying COVID-19 severity. Characteristics of individuals with new diagnoses of FND and migraine following COVID-19 were compared. Results: The incidence of FND was higher in COVID-19 patients with records of hospitalisation (OR 2.165; 95% CI 1.691-2.773) and emergency department visits (OR 1.412; 95% CI 1.069-1.864). Incidence was higher following COVID-19 compared to other RTIs, both in the first 2 years of the pandemic (0.033 vs. 0.021%, OR 1.555, 95% CI 1.271-1.902) and subsequently (0.038 vs. 0.027%, OR 1.394, 95% CI 1.173-1.657). Medical, neurological, and psychiatric comorbidities were more common in newly diagnosed post-COVID-19 FND compared to migraine. Conclusions: New-onset FND appears more likely after COVID-19 than other RTIs. Both the severity of the triggering illness and pre-existing individual vulnerability may contribute to the development of FND.</dc:description><dc:date>2025</dc:date><dc:date>2026-04-10 15:15:29</dc:date><dc:type>Neznano</dc:type><dc:identifier>28889</dc:identifier><dc:identifier>UDK: 616.8</dc:identifier><dc:identifier>ISSN pri članku: 1468-1331</dc:identifier><dc:identifier>DOI: 10.1111/ene.70459</dc:identifier><dc:identifier>COBISS_ID: 263346435</dc:identifier><dc:language>sl</dc:language></metadata>
